Dialoxygenation: a Preclinical Trial for Transforming the Artificial Kidney Into an Oxygenator

dc.contributor.author Karacanoglu, Dilek
dc.contributor.author Bedir, Esra
dc.contributor.author Nakip, Ozlem Saritas
dc.contributor.author Kesici, Selman
dc.contributor.author Duran, Hatice
dc.contributor.author Bayrakci, Benan
dc.date.accessioned 2024-08-18T17:23:07Z
dc.date.available 2024-08-18T17:23:07Z
dc.date.issued 2025
dc.description BEDIR, ESRA/0000-0002-7416-0256; karacanoglu, dilek/0009-0001-9062-345X; Duran Durmus, Hatice/0000-0001-6203-3906 en_US
dc.description.abstract Critically ill patients sometimes require tandem application of extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT) which is easier and cheaper. We aimed to transform the kidney membrane into a lung membrane by adding hydrogen peroxide (H2O2) to the dialysate as the oxygen source. A solution containing H2O2 and a dialysate fluid mixture was used as the final dialysate. Starting with 100% H2O2 solution and gradually reducing the volume of H2O2, respectively: 50%, 10%, 5%, 4%, 3%, 2%, and 1%. PRISMAFLEX system, Prismaflex M60 set and a bag of packed red blood cells (pRBCs) were the prototype. blood flow rate was about 40 ml/minute and the dialysis rate was about 200 ml/m2/minute/1.73 m2. blood sampling times were; at the beginning (T0), at 15th (T1), 30th (T2), 60th (T3) minutes. Amongst eight attempts H2O2 concentration that increased the partial oxygen pressure (pO2) level significantly in a reasonable period, without any bubbles, was 3%. Methemoglobinemia was not observed in any trial. After the test with 3%, H2O2 in the dialysate fluid decreased progressively without any H2O2 detection at post-membrane blood. Three percent H2O2 solution is sufficient and safe for oxygenation in CRRT systems. With this new oxy-dialysate solution, both pulmonary and renal replacement can be possible via a single membrane in a simpler manner. en_US
dc.identifier.doi 10.1097/MAT.0000000000002260
dc.identifier.issn 1058-2916
dc.identifier.issn 1538-943X
dc.identifier.scopus 2-s2.0-85198922978
dc.identifier.uri https://doi.org/10.1097/MAT.0000000000002260
dc.language.iso en en_US
dc.publisher Lippincott Williams & Wilkins en_US
dc.relation.ispartof ASAIO Journal
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Dialo-Oxygenation en_US
dc.subject Extracorporeal Membrane Oxygenation en_US
dc.subject Continuous Veno-Venous Hemodiafiltration en_US
dc.subject Artificial Lung en_US
dc.subject Artificial Kidney en_US
dc.subject Hydrogen Peroxide en_US
dc.subject Biomembrane en_US
dc.subject Oxygenator en_US
dc.title Dialoxygenation: a Preclinical Trial for Transforming the Artificial Kidney Into an Oxygenator en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id BEDIR, ESRA/0000-0002-7416-0256
gdc.author.id karacanoglu, dilek/0009-0001-9062-345X
gdc.author.id Duran Durmus, Hatice/0000-0001-6203-3906
gdc.author.institutional Duran Durmuş, Hatice
gdc.author.wosid kesici, selman/AAA-3950-2022
gdc.author.wosid Duran, Hatice/IZD-7416-2023
gdc.author.wosid Duran Durmus, Hatice/B-1423-2009
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C4
gdc.description.department TOBB University of Economics and Technology en_US
gdc.description.departmenttemp [Karacanoglu, Dilek; Kesici, Selman; Bayrakci, Benan] Hacettepe Univ, Ctr Life Support Practice & Res, Dept Pediat Intens Care Med, Ankara, Turkiye; [Bedir, Esra; Duran, Hatice] TOBB Univ Econ & Technol, Dept Mat Sci & Nanotechnol Engn, Ankara, Turkiye; [Bedir, Esra; Duran, Hatice] Bilkent Univ, UNAM Natl Nanotechnol Res Ctr, Ankara, Turkiye; [Bedir, Esra; Duran, Hatice] Bilkent Univ, Inst Mat Sci & Nanotechnol, Ankara, Turkiye; [Nakip, Ozlem Saritas] Etlik City Hosp, Dept Pediat, Intens Care Unit, Ankara, Turkiye en_US
gdc.description.endpage 98 en_US
gdc.description.issue 1 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 92 en_US
gdc.description.volume 71 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.openalex W4400642264
gdc.identifier.pmid 39008795
gdc.identifier.wos WOS:001385959200003
gdc.oaire.diamondjournal false
gdc.oaire.impulse 2.0
gdc.oaire.influence 3.044441E-9
gdc.oaire.isgreen false
gdc.oaire.keywords Continuous Veno-Venous Hemodiafiltration
gdc.oaire.keywords Oxygenator
gdc.oaire.keywords Partial Pressure
gdc.oaire.keywords Photoelectron Spectroscopy
gdc.oaire.keywords Artificial Kidney
gdc.oaire.keywords Membranes, Artificial
gdc.oaire.keywords Hydrogen Peroxide
gdc.oaire.keywords Oxygenators
gdc.oaire.keywords Oxygen
gdc.oaire.keywords Extracorporeal Membrane Oxygenation
gdc.oaire.keywords Biomembrane
gdc.oaire.keywords Dialysis Solutions
gdc.oaire.keywords Dialo-Oxygenation
gdc.oaire.keywords Humans
gdc.oaire.keywords Artificial Lung
gdc.oaire.keywords Blood Gas Analysis
gdc.oaire.keywords Kidneys, Artificial
gdc.oaire.popularity 4.3376063E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0302 clinical medicine
gdc.openalex.fwci 2.12050682
gdc.openalex.normalizedpercentile 0.82
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 0
gdc.plumx.crossrefcites 2
gdc.plumx.mendeley 1
gdc.plumx.pubmedcites 1
gdc.plumx.scopuscites 3
gdc.scopus.citedcount 3
gdc.wos.citedcount 3
relation.isAuthorOfPublication db0e3cfb-6d3c-4124-95d0-561259f36dea
relation.isAuthorOfPublication.latestForDiscovery db0e3cfb-6d3c-4124-95d0-561259f36dea
relation.isOrgUnitOfPublication 491811c3-9c59-4e5f-ade5-8ff67b09dbb4
relation.isOrgUnitOfPublication a9abd75e-3cd8-44b3-a2bb-d7c72a7e2f1d
relation.isOrgUnitOfPublication 80088808-d92c-4251-ad3e-435c98e0ac85
relation.isOrgUnitOfPublication.latestForDiscovery 491811c3-9c59-4e5f-ade5-8ff67b09dbb4

Files